Skip to search formSkip to main contentSkip to account menu

anagrelide

Known as: Anagrelida, Anagrelidum, anagrelide [Chemical/Ingredient] 
A synthetic quinazoline derivative, Anagrelide reduces platelet production through a decrease in megakaryocyte maturation. Anagrelide inhibits cyclic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Philadelphia negative (Ph-neg) myeloproliferative neoplasms (MPN) are a heterogenous group of clonal stem cell disorders… 
Review
2018
Review
2018
Abstract We report a case of Prinzmetal angina as inaugural manifestation of coronary disease, in a young adult male patient… 
Review
2013
Review
2013
This issue of the Journal includes the first article in a series of review articles on global health.1 In a journal that proudly… 
2012
2012
A new RP-HPLC method was developed and validated for the determination of an anti-thrombocythemic agent anagrelide in pure and… 
2009
2009
A simple, accurate and sensitive voltammetric method for determination of Anagrelide (ANG) using β cyclodextrin modified carbon… 
Review
2008
Review
2008
Anagrelide, a phospholipase A2 inhibitor that inhibits megakaryocyte proliferation, is used in the management of thrombocythemia… 
2003
2003
Background : Thrombocytosis can result in life-threatening thrombotic or hemorrhagic events. Anagrelide acts exclusively on… 
2003
2003
SummaryAbstractImatinib mesylate (Gleevec®, Glivec®) is an orally administered competitive inhibitor of the BCR-ABL tyrosine… 
1998
1998
To the Editor: Patients receiving hydroxyurea have been reported to have development of painful leg ulcers,'> among other… 
1986
1986
The effects of the potent platelet aggregation inhibitor, anagrelide (6,7-dichloro-1,5-dihydroimidazo(2,1-6)quinazolin-2(/sup 3/H…